You are using an outdated browser. Upgrade your browser to better experience this site.

Novocure at SNO
Annual Meeting 2017

Check out our presence at this year’s 22nd Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology


#SNO2017

60

total abstracts

37

TTFields clinical abstracts

13

TTFields pre-clinical abstracts

6

EF-14 sub-group analyses

47

abstracts with an external lead author

calendar of events

press
releases

There will be 60 abstracts at SNO’s 2017 Annual Meeting showcasing the use of Novocure’s Tumor Treating Fields technology.

View the EF-14 Clinical Presentations Release    View the Preclinical Presentations Release    View the Simulation Presentations Release   
View the externally led clinical research presentations release    View the EF-14 survival data release   

mechanism
of action

Tumor Treating Fields is a cancer treatment that uses electric fields to disrupt cell division, inhibiting tumor growth and potentially causing dividing cancer cells to die.

Learn more about TTFields   

media
center

MEDIA
REQUESTS

For media requests, please click the link below.

media@novocure.com  

Press
kit

To access Novocure’s press kit, please click the link below.

novocure press kit